You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
Successful Medication Not Covered for Long-Term Therapy
Sibutramine (Meridia) is well tolerated by most patients and considered to be a safe drug. It has been shown to promote successful weight loss in most patients.
However, in order to keep the weight off, the drug must be continued on a long-term basis.
A recent British study analyzed the impact of weight loss from sibutramine on a diet and exercise program in a “healthy obese” population. Researchers found that sibutramine works when combined with a diet and exercise program.
However, most insurance companies in the United States do not reimburse for sibutramine. Those insurers that do pay for this drug usually limit the duration to three months, which is essentially worthless.
It is necessary for the FDA to approve weight-loss drugs (such as Meridia and Xenical) for long-term use for patients with pre-diabetes and metabolic syndrome.
Unfortunately, even if they are approved by the FDA, it is doubtful that the insurance industry will agree to reimburse for these medications for the increasing numbers of “healthy obese” individuals in this country.
Meridia (sibutramine) is cost-effective treatment for obesity when combined with diet and lifestyle change.
—Medical Decision Making, February 2004
Categories: Diabetes, Diabetes, Type 2 Issues, Weight Loss
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...